|
|
Other links at Articles > Hematology-Oncology |
| 2. |
Can Cancer Be Cured by Combination Therapy?
|
|
|
The emphasis in clinical cancer trials on using combination therapies to shut down the EGFR pathway prompts Dr. John Marshall to ask whether this approach represents progress or a return to a failed past. Medscape Hematology-Oncology
|
| 5. |
Does Switch Maintenance Benefit Patients With NSCLC?
|
|
|
In patients with partial response to initial therapy, is there benefit to switching to a new agent for maintenance therapy? Dr. Mark Kris examines studies that address this question. Medscape Hematology-Oncology
|
|
|